Morphic Therapeutic
MORF
$29.90
Share price
4.14%
Change (1 day)
-38.34%
Change (1 year)
Categories
P/S ratio for Morphic Therapeutic (MORF)
P/S ratio as of May 2024 (TTM): N/A
According to Morphic Therapeutic's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2023 the company had a P/S ratio of > 1000.
P/S ratio history for Morphic Therapeutic from 2019 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | > 1000 | 18832.04% |
| 2022 | 14.6 | -83.54% |
| 2021 | 88.5 | 269.97% |
| 2020 | 23.9 | -21.43% |
| 2019 | 30.4 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 1.05 | N/A | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 92.5 | N/A | 🇺🇸 USA |